PROGRAM OVERVIEW

Join us in September as we come together for our Fall Scientific Sessions in Orlando, FL. From highlighting clinical pearls and the latest in lipidology, to making new connections and learning techniques to better manage your patients, we look forward to bringing our community together, where all of lipidology meets.

We hope you will joining us in-person, but we will be live-streaming the sessions for those who are unable to join us in Orlando.


NLA 2021 Fall Scientific Sessions
IN-PERSON at the Omni Championsgate in Orlando, FL
September 24-26, 2021


  • The NLA 2021 Fall Scientific Sessions is our IN-PERSON meeting to be held at the Omni Championsgate in Orlando, FL from September 24 – 26, 2021.
  • In-person attendees can participate in the pre-conference courses (separate registration and fees) and the live, main sessions in Orlando.
  • The in-person meeting provides unlimited opportunities for networking and includes all social functions, symposia and expert theaters.
  • On-demand viewing of all recorded lectures will be available for 30 days after the Sessions.


NLA 2021 Fall Scientific Sessions
VIRTUAL from Orlando, FL
September 24-26, 2021


  • The NLA Fall Scientific Sessions VIRTUAL is being broadcast via live-stream from September 24 – 26, 2021 on our virtual platform for those unable to join us in Orlando.
  • CME/CE credits are earned for attending each session during the live meeting.
  • On-demand viewing of all recorded lectures will be available for 30 days after the Sessions.
You may need to disable administrative overlay in your Drupal record

Edit Parent - VENUE (visibility Show)

HOTEL


Omni ChampionsGate Orlando
1500 Masters Boulevard
Championsgate, FL 33896

NLA Contracted Rate: $159/night + tax and $15/night resort fee

Room Reservation Cutoff: The NLA hotel block cutoff date has passed.  The negotiated room rate will be available based on hotel room inventory. You must call (407) 390-6664 to request a room at the NLA's negotiated rate. 

Delete VENUE

Edit Parent - PROGRAM (visibility Show)

ANCILLARY COURSES


Foundations of Lipidology

Live, In-person Course

Wednesday, September 22 • 9:00 AM – 6:35 PM ET

Thursday, September 23 • 9:00 AM – 3:30 PM ET

$550 NLA Members, $950 Non-Members, $0 Trainees

 

Overview

The NLA's Foundations of Lipidology course provides an introductory review of the core curriculum in Clinical Lipidology. This course is designed for any healthcare professional seeking to learn the fundamentals of Lipidology. Experts in Lipidology will lecture on basic concepts and guide participants through interactive learning scenarios that provide the knowledge and tools necessary to work effectively in a lipid practice and prepare for advanced training.

This course is particularly useful to review core elements of Clinical Lipidology and is appropriate for clinicians from the full spectrum of clinical experience including Physicians, Physician Assistants, Nurse Practitioners, Pharmacist, Exercise Physiologists, and Dietitians who are in any phase of training, or even experienced physicians who are looking to take a deeper dive into Lipidology.

The Foundations of Lipidology is offered as a two-day course prior to NLA meetings (Clinical Lipid Updates [CLU] and Scientific Sessions).

More Information

Masters

Live, In-person Course

Wednesday, September 22 • 8:30 AM – 6:45 PM ET

Thursday, September 23 • 8:30 AM – 3:20 PM ET

$750 NLA Members, $1,250 Non-Members, $395 Trainees

 

Overview

The NLA's Masters in Lipidology course provides an advanced examination of the core curriculum in Clinical Lipidology. This course is designed for any health care professional with experience in Lipidology who desires advanced training. Experts in the field of Lipidology will lecture on advanced concepts and guide participants through interactive learning scenarios that provide tools and skills to further advance personal standards of practice.

This course is particularly useful to explore the details of Clinical Lipidology and is appropriate for clinicians from the full spectrum of clinical experience including Physicians, Physician Assistants, Nurse Practitioners, Pharmacist, Exercise Physiologists, and Dietitians who are in any phase of training, or even experienced physicians who are looking to take a deeper dive into Lipidology.

Masters in Lipidology is offered as a 2-day course prior to NLA meetings (Clinical Lipid Updates [CLU] and Scientific Sessions).

More Information

ACCREDITATION


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 13.75 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician Credit Designation Statement
The National Lipid Association designates this live activity for a maximum of 13.75 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in this activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 13.75 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL002.

Pharmacist Accreditation Statement

Universal Activity Number JA0007192-0000-21-027-L01-P (Application)

This Activity has been approved for 13.75 contact hour(s) (1.375 CEUs) of the Accreditation Council for Pharmacy Education

 

Nursing
The maximum number of hours awarded for this CE activity is 13.75 contact hours.

Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

EDUCATION OVERVIEW


Target Audience

This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses, and registered dietitians with an interest in lipid management.

Type of Activity
Live, Application

Educational Objectives

At the conclusion of this activity, all participants should be able to:

  • Discuss strategies to improve the knowledge, skills or performance of the healthcare team;

Session I: Update on the Dyslipidemia Research Pipeline

  • Appraise emerging pharmacologic management options for dyslipidemia.
  • Discuss recent and ongoing clinical trials and their role in the treatment of dyslipidemia.

Session II: Hot off the Press – NLA Scientific Statements

  • Review current literature of importance to the science and practice of clinical lipidology.

Session III: Unusual Cases in Clinical Lipidology

  • Evaluate the management of patients with lipid related issues through case discussions.

ORION Data - Special Virtual Lecture

  • Discuss recent clinical trials and their role in the treatment of dyslipidemia.

Session IV: Elucidating the Evidence: The Relationship between Lipoproteins and CV Risk

  • Discuss the potential role of various lipoproteins in risk assessment and the management of CVD.

W. Virgil Brown Distinguished Achievement Award and Lectureship

  • Evaluate the management of patients with dyslipidemia.

Session V: An Update from the Experts: What Your Colleagues Should Know

  • Discuss strategies to improve the knowledge, skills or performance of the healthcare team.

Session VI: New Dietary Guidelines for Americans - Summary Session

  • Discuss the implications of the new dietary guidelines for Americans on the treatment of patients with dyslipidemia.

Session VII: Individual Health Inequities in the US

  • Recognize population differences that may impact clinical care.

Session VIII: Oral Poster Presentations

  • Critically appraise emerging research and its applications to daily clinical practice.

Session IX: What the Lipid Specialist Needs to Know About the Intersection Between Medications used to Treat Diabetes and Other Diseases: An Evidence-Based Updated?

  • Appraise pharmacologic management options for dyslipidemia.

AGENDA


Friday, September 24, 2021
8:00 - 9:00 AM Welcome Back Breakfast for NLA Members
9:00 - 9:10 AM Opening Remarks
9:10 - 10:35 AM Session I - Update on the Dyslipidemia Research Pipeline
9:10 - 9:15 AM Pre-Session Assessment

9:15 - 9:35 AM

CV Outcome Trials Kevin C. Maki, PhD, CLS, FNLA
9:35 - 9:55 AM Triglyceride and Lp(a) Lowering Medications Christie M. Ballantyne, MD, FNLA
9:55 - 10:15 AM LDL Lowering Therapies - One Size Doesn't Fit All Mary P. McGowan, MD, FNLA
10:15 - 10:35 AM Post-Session Assessment and Question & Answer Panel
10:35 - 10:40 AM Break
10:40 AM - 12:05 PM Session II - Hot Off the Press: NLA Scientific Statements
10:40 - 10:45 AM Pre-Session Assessment
10:45 - 11:05 AM

NLA Scientific Statement: Lipid Measurements in the Management of Cardiovascular Diseases: Practical Recommendations

Peter W.F. Wilson, MD, FNLA
11:05 - 11:25 PM Post-Session Assessment and Question & Answer 
11:25 - 11:45 PM NLA Scientific Statement: Genetic Testing in Dyslipidemia P. Barton Duell, MD, FNLA
11:45 AM - 12:05 PM Post-Session Assessment and Question & Answer
12:05 - 1:05 PM Expert Theater
12:05 - 1:05 PM

Lunch

1:10 - 2:50 PM Session III – Unusual Cases in Clinical Lipidology
1:10 - 1:15 PM Pre-Session Assessment
1:15 - 1:30 PM Case Presentations Kevin P. Forey, II, MD, MBA
1:30 - 1:50 PM Liver Disease Kenneth Cusi, MD
1:50 - 2:10 PM Implementation of Cholesterol-Lowering Therapy to Reduce Risk Persons Living with HIV Robert S. Rosenson, MD, FNLA
2:10 - 2:30 PM Assessing and Reducing ASCVD Risk in Patients with Autoimmune Rheumatologic Diseases Karen E. Aspry, MD, MS, FNLA
2:30 - 2:50 PM Post-Session Assessment and Question & Answer Panel
2:50 - 3:00 PM Break
3:00 - 3:30 PM

SPECIAL LECTURE: ORION Data with Kausik Ray, MBChB, MD, MPhil

3:30 - 4:30 PM

SPECIAL PANEL DISCUSSION – THE IMPACT OF THE ORION Data

Moderator: James A. Underberg, MD, MS, FNLA*

Panelist:

Eugenia Gianos, MD, FNLA* ,

Daniel E. Soffer, MD, FNLA*,

Salim S. Virani, MD, PhD

5:00 - 6:00 PM Welcome Reception
6:00 - 7:00 PM NLA Honors and Awards Ceremony
Saturday, September 25, 2021
7:00 - 9:00 AM CME/CE Symposium
This is an independent satellite CME/CE symposium held in conjunction with the NLA 2021 Scientific Sessions. It is not part of the official sessions as planned by the NLA Scientific Meetings Committee.
8:00 - 8:50 AM Breakfast in Exhibit Hall
9:05 - 10:25 AM Session IV - Elucidating the Evidence: The Relationship Between Lipoproteins and CV Risk
9:05 - 9:10 AM Pre-Session Assessment
9:10 - 9:30 AM Lp(a) Zareen Farukhi, MD, MPH
9:30 - 9:50 AM Evolving Concepts in LDL-C Lowering in 2021: Challenges and Opportunities Salim S. Virani, MD, PhD
9:50 - 10:10 AM Triglycerides and non-HDL-C Kevin C. Maki, PhD, CLS, FNLA
10:10 - 10:25 AM Post-Session Assessment and Question & Answer Panel  
10:25 - 11:15 AM Abstract Question & Answer/Break in Exhibit Hall
11:15 - 11:30 AM NLA President's Address Joseph J. Saseen, PharmD, CLS, FNLA
11:30 AM - 12:05 PM W. Virgil Brown Distinguished Achievement Award and Lectureship Peter W.F. Wilson, MD, FNLA
12:05 - 1:05 PM Expert Theaters/Lunch in Exhibit Hall
1:05 - 3:00 PM Session V - Update from the Experts: What Your Colleagues Should Know
1:05 - 1:10 PM Pre-Session Assessment
1:10 - 1:25 PM The Interprofessional Team Joseph J. Saseen, PharmD, CLS, FNLA
1:25 - 1:45 PM Medication Adherence: Why Your Patients Aren’t Taking Their Meds (and What You Can Do About It) Steven Orlando, PharmD
1:45 - 2:05 PM Nutrition Lauren A. Williams, RD
2:05 - 2:25 PM Shared Decision Making to Reduce ASCVD Risk Lynne T. Braun, PhD, CNP, CLS, FNLA
2:25 - 2:40 PM Fireside Chat on Importance of Integrating the Team Panel
2:40 - 3:00 PM Post-Session Assessment and Question & Answer Panel
3:00 - 3:05 PM  Break
3:05 - 4:10 PM Session VI - New Dietary Guidelines for Americans - Summary Sessions
3:05 - 3:10 PM Pre-Session Assessment
3:10 - 3:30 PM History: What is Different? 

Kristina Petersen, PhD

3:30 - 3:50 PM What Was Included and What Wasn't? Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA
3:50 - 4:10 PM Post-Session Assessment and Question & Answer Panel
4:10 - 4:15 PM Break
4:15 - 5:40 PM Session VII - Individual Health Inequities in the US
4:15 - 4:20 PM Pre-Session Assessment
4:20 - 4:40 PM Overview of Health Inequities Keith C. Ferdinand, MD, FNLA
4:40 - 5:00 PM Health Inequities: Hispanics with Diabetes Anekwe Onwuanyi, MD
5:00 - 5:20 PM Health Inequities: African Americans Angela L. Brown, MD
5:20 - 5:40 PM Post-Session Assessment and Question & Answer Panel  
8:30 - 10:30 PM Foundation of the NLA Event
Sunday, September 26, 2021
8:00 - 8:50 AM Breakfast in Exhibit Hall
9:00 - 10:00 AM Session VIII - Oral Poster Presentations
9:00 - 9:10 AM Introductions and Abstract Award Presentations
9:10 - 9:20 AM 3rd Place Oral Presentation
9:20 - 9:30 AM 2nd Place Oral Presentation
9:30 - 9:40 AM 1st Place Oral Presentation
9:40 - 9:50 AM 1st Place Young Investigator Presentation
9:50 - 10:00 AM FH Hunninghake Award Winner Presentation
10:00 - 11:00 AM Abstract Question & Answer/Break in Exhibit Hall
11:00 AM - 11:30 AM Late Breakers
11:30 AM - 12:30 PM Expert Theaters/Lunch in Exhibit Hall
12:30 - 2:15 PM Session IX: What the Lipid Specialist Needs to Know About the Intersection Between Medications Used to Treat Diabetes and Other Diseases: An Evidence-Based Update
12:30 - 12:35 PM Pre-Session Assessment
12:35 - 12:55 PM What the Lipid Specialist Needs to Know about Managing Cardiometabolic Risk with "Diabetes" Medications

Kathleen Wyne, MD, PhD, FNLA

12:55 - 1:15 PM Chronic Kidney Disease Joseph A. Nardolillo, PharmD
1:15 - 1:35 PM Heart Failure Karen Friday, MD
1:35 - 1:55 PM Obesity Sheldon Litwin, MD
1:55 - 2:15 PM Post-Session Assessment and Question & Answer Panel
Delete PROGRAM

WELLNESS CHALLENGE


Join us for an exciting three-month challenge designed to encourage you and your colleagues, family, and friends to incorporate heart-healthy activity in your everyday life.

Edit Parent - WELLNESS CHALLENGE (visibility Show)

Activity Details


Broken up into two activity sessions and a 5K, this challenge offers a user-friendly, integrated platform (supported by iOS and Android) where you can track a variety of activities including walking, running and yoga. Join us for milestone activities throughout the challenge to motivate your peers and share your progress on social media along the way.

  • Activity Session 1: Friday, July 9 - Monday, August 16
  • Activity Session 2: Thursday, August 19 - Sunday, September 26
  • 5K: Sunday, September 26 

You can particpate in one or both challenges and the 5K! Win Prizes and you can even compete on your NLA Chapter team for bragging rights in addition to competing as an individual! Keep us updated on your progress by using #NLAWellness on social media.

Sponsored by Novartis

LEARN MORE

Check out a special message from our Challenge sponsor!

Let's make cardiovascular disease (CVD) history

As an expert in cardiovascular care, you know that CVD is the single largest cause of death in the US year after year, and growing. Lowering LDL-C and keeping it low is one of the best ways to reduce risk. However, up to 80% of patients currently on treatment are unable to reach the recommended LDL-C threshold of < 70 mg/dL, leaving them at a significant risk for CV events.

We already know the great lengths you go to encourage your patients to live healthy lives. But now more than ever, it is important to lead a legacy of positive change by pledging your support to empower your patients with CVD. Together, we can help patients achieve their LDL-C goals and reduce their CV risk. Learn more and take the pledge
Delete WELLNESS CHALLENGE

Edit Parent - SPECIAL EVENTS (visibility Show)

FOUNDATION EVENT


An Evening with the Foundation of the NLA

Join the Foundation of the National Lipid Association (NLA) for our annual fundraiser during the NLA’s 2021 Scientific Sessions.

We are looking forward to hosting you in Orlando for an evening of dessert, drinks, live music, dancing, and a silent auction benefiting the Foundation of the NLA. Your presence and dedication to the Foundation will be in support of our work in 2022 and beyond, including health screenings in underserved populations, resources for rare disease patients, public health awareness campaigns, and much more. Visit Lipid.org/Sessions to purchase your tickets today!


Saturday, September 25
8:30 – 10:30pm EST
Omni Orlando Resort at Championsgate
International Ballroom III
$150/person

 

Register Now

 

Expert Theaters


Friday, September 24 | 12:05pm - 1:05pm

Managing & Living with HoFH: Focus on Juxtapid

Location: Congressional Room, Omni ChampionsGate Orlando

Speaker:
David Jermey Davidson, MD, FACC

Hosted by Amryt Pharma


A Focus on Very High-Risk Patients in the Acute Setting: Understanding Vulnerable Plaque and Prioritizing LDL-C

Location: Colonial Room, Omni ChampionsGate Orlando

Speaker:
Leandro Slipczuk MD, PhD, FACC

Hosted by Amgen

Saturday, September 25 | 12:05pm - 1:05pm

Add on Efficacy. Oral, Nonstatin Therapies for Lowering LDL-C

Location: Congressional Room, Omni ChampionsGate Orlando

Event Overview:
The session will cover the following information:

  • Atherosclerotic cardiovascular disease and lipid management
  • Unique mechanism of action for two treatment options
  • Efficacy data for two treatment options
  • Safety data for two treatment options
  • Overview of the ongoing Outcomes trial

Speaker:
Dean G. Karalis, MD, FACC, FNLA
Clinical Professor of Medicine
Sidney Kimmel Medical College 
Thomas Jefferson University Hospital
Philadelphia, PA

Hosted by Esperion


Help Your Recent MI Patients Achieve Lower LDL-C and Reduce the Risk of Another MI

Location: Colonial Room, Omni ChampionsGate Orlando

Event Overview:
Join Dr. Underberg for an educational presentation on the treatment of very high-risk ASCVD patients described in the 2018 ACC/AHA Guideline on the Management of Blood Cholesterol. Hear about his experience and the treatment options available for appropriate patients. 

Speaker:
James A. Underberg, MD, MS, FACPM, FACP, FNYAM, FASPC, FNLA

Hosted by Amgen

Sunday, September 26 | 11:30am - 12:30pm

What You Need to Know About Lp(a) With Cardiovascular Disease "The Interconnected Risk"

Location: Congressional Room, Omni ChampionsGate Orlando

Event Overview:

  • Review evidence supporting lipoprotein(a) [Lp(a)] as an independent and likely causal risk factor for atherosclerotic and calcific aortic valve disease (CAVD)
  • Elevated Lp(a) and implications for diagnosis of FH
  • Implications of elevated Lp(a) regarding ASCVD and CAVD risk in patients
  • Review Lp(a) lowering therapies

Speakers:
Joyce L. Ross, MSN, ANP, CS, CRNP, CLS, FNLA, FPCNA, moderator

James A. Trippi, MD

Gisette Reyes-Soffer, MD

Hosted by Kaneka Medical America, LLC


EVKEEZA® (evinacumab-dgnb) for Homozygous Familial Hypercholesterolemia

Location: Colonial Room, Omni ChampionsGate Orlando

Speaker: 

James A. Underberg, MD, MS, FACPM, FACP, FNYAM, FASPC, FNLA

Hosted by Regeneron Pharmaceuticals, Inc.

SYMPOSIA


 

Optimizing LDL-C Reduction with Oral Therapy: Featuring the Wheel of Knowledge Challenge
 
Saturday, September 25

7:00 – 7:30 AM | Registration and Breakfast
7:30 – 9:00 AM |
Educational Symposium
 

In the United States, cardiovascular disease is the leading cause of death, claiming over 800,000 lives annually. Dyslipidemia is a major risk factor for adverse cardiovascular outcomes, with 30% of US adults having elevated LDL-C (≥130 mg/dL). While many patients with elevated LDL-C benefit from statin therapy, about 10% to 30% have statin intolerance or dose-limiting toxicities, leaving them at risk for adverse cardiovascular events. Add-on medications may further reduce LDL-C for these patients; however, clinicians are not knowledgeable about the benefits of these drugs. In this educational activity featuring the fun and engaging Wheel of Knowledge Challenge, expert clinicians discuss the latest updates regarding LDL-C lowering medications.

 

Activity Chair: Peter Jones, MD, FACP, FNLA
Faculty: Gina Price Lundberg, MD, FAHA, FACC | Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC
 

Hosted by Vindico Medical Education
Breakfast provided by the NLA
 
This is an independent satellite CME/CE symposium held in conjunction with the NLA 2021 Scientific Sessions. It is not part of the official sessions as planned by the NLA Scientific Meetings Committee.
Delete SPECIAL EVENTS


SCIENTIFIC MEETINGS CO-CHAIRS

Joseph J. Saseen, PharmD, CLS, FNLA

Program Planner
President, National Lipid Association

Professor and Vice Chair
Clinical & Academic Programs
Department of Clinical Pharmacy
University of Colorado Anschutz Medical Campus
Skaggs School of Pharmacy
Aurora, CO

Peter H. Jones, MD, FNLA

Program Planner
Associate Professor
Baylor College of Medicine
Houston, TX



PROGRAM PLANNERS

Casey Elkins, DNP, MEd, NP-C, CLS, FNLA

Program Planner
Assistant Dean for Academic Affairs
Director, DNP Program
University of South Alabama
College of Nursing
Mobile, AL

Eugenia Gianos, MD, FNLA

System Director
Cardiovascular Prevention
Northwell Health
Director
Women's Cardiovascular Program
Lenox Hill Hospital
Associate Professor of Cardiology
Hofstra School of Medicine
New York, NY

Anne C. Goldberg, MD, FACP, FNLA

Committee Co-Chair
President, Foundation of the NLA

Professor of Medicine
Washington University School of Medicine
St. Louis, MO

Kevin C. Maki, PhD, CLS, FNLA

Executive Council Chair, National Lipid Association
Adjunct Professor
Department of Applied Health Science
School of Public Health
Indiana University
Bloomington, IN
Chief Scientist
Midwest Biomedical Research
Chicago, IL

James A. Underberg, MD, MS, FNLA

Past- President, National Lipid Association
Clinical Assistant Professor of Medicine
NYU School of Medicine & NYU Center for Prevention of Cardiovascular Disease
Director
Bellevue Hospital Lipid Clinic
New York, NY

Lauren Williams, MCN, RD, LD

Clinical Dietitian II
Endocrinology - REACH Clinic
Cook Children’s Medical Center
Fort Worth, TX

Mary Katherine Cheeley, PharmD, CLS, FNLA

Clinical Pharmacist Specialist
Grady Health System
Atlanta, GA

Nihar R. Desai, MD, MPH

Associate Professor of Medicine
Yale School of Medicine
Associate Chief
Section of Cardiovascular Medicine
Yale New Haven Health System
New Haven, CT



FACULTY

Christie M. Ballantyne, MD, FNLA

Committee Co-Chair
Professor of Medicine
Vice Chair of Research for the Department of Medicine
Chief, Section of Cardiovascular Research
Chief, Section of Cardiology
Department of Medicine
Baylor College of Medicine
Houston, TX

Lynne T. Braun, PhD, CNP, CLS, FNLA

Professor, Colleges of Nursing and Medicine
Rush University
Nurse Practitioner
Rush Heart Center for Women
Rush University Medical Center
Chicago, IL

Angela L. Brown, MD

Associate Professor of Medicine
Division of Cardiology
Washington University School of Medicine
St. Louis, MO

Emily E. Brown, MGC, CGC

Certified Genetic Counselor
Center for Inherited Heart Disease
Johns Hopkins University
Baltimore, MD

 

 

 

Keith C. Ferdinand, MD, FNLA

Professor of Medicine
School of Medicine
Tulane University
New Orleans, LA

Carol Kirkpatrick, PhD, RDN, MPH, CLS, FNLA

Program Planner
Director/Clinical Associate Professor
Wellness Center
Idaho State University
Kasiska Division of Health Sciences
Pocatello, ID

Kevin C. Maki, PhD, CLS, FNLA

Executive Council Chair, National Lipid Association
Adjunct Professor
Department of Applied Health Science
School of Public Health
Indiana University
Bloomington, IN
Chief Scientist
Midwest Biomedical Research
Chicago, IL

Kristina Petersen, PhD

Assistant Professor
Department of Nutritional Sciences
Texas Tech University
Lubbock, TX

Salim S. Virani, MD, PhD

Professor, Section of Cardiovascular Research
Director, Cardiology Fellowship Training Program
Baylor College of Medicine
Houston, TX

Peter W.F. Wilson, MD, FNLA

Professor of Medicine and Public Health
Emory University
Atlanta, GA

Karen E. Aspry, MD, MS, FNLA

Director, Lipid Clinic and Cardiovascular
  Disease Prevention Program
Lifespan Cardiovascular Institute
East Greenwich, RI



Disclaimer


Lipid Bucks: Lipid Bucks can be applied on the checkout page.

Registration: Online registration and payment must be received no later than September 21, 2021. By registering for this meeting, attendee understands and agrees that attendee’s name, city, and state may be shared with other attendees and exhibitors. By visiting the exhibit hall, attendee understands, agrees and consents to the sharing of attendee’s contact information with the participating companies.

Photography: Photographs and/or video may be taken as part of the registered event. By registering for this event, you grant the National Lipid Association full rights to use the images resulting from the photography/video filming and any reproductions or adaptations of the images for promotional purposes. This may include (but is not limited to), the right to use them in print and online platforms, social media, press releases and other outlets.

Cancellation: Telephone cancellations will not be accepted. A written notice of cancellation must be received no later than September 1, 2021. There will be a $50 fee for all cancellations. There will be no refunds if cancelling within 30 days of the start of the meeting date.

Attendees who need special reasonable accommodations or who have special needs should contact the meeting organizers at 904-998-0854.